Eric is a biotechnology executive with more than 25 years of leadership experience across the life sciences industry. He is currently a Venture Partner at Samsara BioCapital, where he also supports portfolio companies through board and advisory roles. Over the course of his career, he has raised more than $2 billion in equity financing and secured over $500 million through strategic partnering deals, supporting the development of novel therapeutics in oncology, autoimmune, and kidney diseases.
Previously, Eric served as President and CEO of Chinook Therapeutics and, prior to that, as President and CEO of Silverback Therapeutics. He spent more than 15 years at Seattle Genetics, most recently as Chief Operating Officer, where he led business development, corporate strategy, manufacturing, and alliance management, and played a key role in raising more than $1.2 billion in equity capital and executing multiple strategic collaborations.